Pacer Advisors
KURA icon

Pacer Advisors’s Kura Oncology KURA Stock Holding History

Pacer Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-709
Closed -$14.6K – 2631
2024
Q2 		$14.6K Sell
709
-742
-51% -$15.3K ﹤0.01% 3489
2024
Q1 		$30.9K Buy
+1,451
New +$28.2K ﹤0.01% 3349
2021
Q2 		– Sell
-2,618
Closed -$74K – 1488
2021
Q1 		$74K Sell
2,618
-558
-18% -$17.7K ﹤0.01% 1351
2020
Q4 		$104K Buy
3,176
+1,804
+131% +$63.4K ﹤0.01% 1362
2020
Q3 		$42K Buy
+1,372
New +$30.3K ﹤0.01% 1309
2018
Q4 		– Sell
-2,518
Closed -$44K – 816
2018
Q3 		$44K Buy
+2,518
New +$48.3K ﹤0.01% 1149

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors's KURA Position: Q3 2024 in Review

Pacer Advisors sold out of Kura Oncology (KURA) in Q3 2024, closing a stake of 709 shares — an estimated $14.6K sold.

Pacer Advisors first reported a position in KURA in Q3 2018 and held it in 6 quarters. The position peaked at $104K in Q4 2020. 179 funds tracked by Wall St. Rank hold KURA as of Q3 2024.

  • Pacer Advisors reported no remaining Kura Oncology position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 709 Kura Oncology shares in Q3 2024, an estimated $14.6K.
  • Pacer Advisors first reported a position in Kura Oncology in Q3 2018 and held it in 6 quarters.
  • Pacer Advisors's Kura Oncology position peaked at $104K in Q4 2020.
  • 179 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.